mRNA rabies vaccine induces durable immune response in macaques

FHS
June 27, 2023
2:57 am

Novel mRNA vaccine for rabies shows enhanced immune response with higher antibody levels and improved cross-neutralization, indicating potential for a broadly protective vaccine against related lyssavirus strains.

Elucida Oncology nabs more funds for its take on ADCs, sees potential in radiotherapy partnership

Elucida Oncology has raised another approximately $30 million to bring its version of antibody-drug conjugates to more patients in the clinical setting, the company told

June 24, 2023

Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – January 29, 2024) – Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the “Company”), a western Canadian-based life sciences company, is

January 29, 2024

New review unveils the increased risks of forced separation between humans and their pets

Pet owners forced to be separated from their animals in crisis situations, including those who are victims of domestic violence, are suffering from a lack

January 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.